Breadcrumb Home Diabetes Policy FDA allows automatic 'generic' swap for brand-name insulin Medicare Though millions are at risk for diabetes, Medicare struggles to expand prevention program Payment Medicare telehealth access preserved in physician pay rule—for now Supply Chain What Walmart's lower-priced insulin means for the market Legal Paris court convicts, fines pharma firm for deadly diet pill Safety & Quality 'Painless' glucose monitors pushed despite little evidence they help most diabetes patients Providers Cone Health shutters pricey digital diabetes venture Payment CMS signs off on new payments to encourage home dialysis Care Delivery Hospitals, clinics may be ready to adopt wearable tech Safety & Quality Data Points: An epidemic and pandemic collide Load More Sponsored Content
